Ocular Abnormalities in Patients Treated With a Novel Anti-Gd2 Monoclonal Antibody, Hu14.18K322A

Journal of AAPOS - United States
doi 10.1016/j.jaapos.2014.11.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2005English

Phase I Trial of Anti-Gd2 Monoclonal Antibody Hu3F8 Plus GM-CSF: Impact of Body Weight, Immunogenicity and Anti-Gd2 Response on Pharmacokinetics and Survival

OncoImmunology
OncologyAllergyImmunology
2017English

A Monoclonal Antibody to O-Acetyl-Gd2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity Without Peripheral Nervous System Cross-Reactivity

PLoS ONE
Multidisciplinary
2011English

Long-Term Continuous Infusion of Anti-Gd2 Antibody CH14.18/CHO in Relapsed/Refractory Neuroblastoma Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Anti-Antibody Activity of a Monoclonal Macroglobulin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1971English

A Novel Phosphatidylserine-Binding Peptide Motif Defined by an Anti-Idiotypic Monoclonal Antibody

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Multispecificity of a Recombinant Anti-Ras Monoclonal Antibody

Journal of Molecular Recognition
Structural BiologyMolecular Biology
2017English

Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy